Biological Ethics

Kaczynski and Weizenbaum arrived at the same destination from opposite directions: that a code of ethics for biotechnology doesn't restrain power but exercises it. Kaczynski's argument is blunt — whoever writes the ethical code imposes their values on the genetic constitution of everyone else, making "medical ethics" a tool of class control rather than a check on it. Weizenbaum reaches the same structure more carefully: the very act of choosing which scientific questions to pursue (and which to leave alone) is a value judgment that scientists refuse to acknowledge as such, hiding selection bias behind the language of neutrality. Anderson's reporting from the global South confirms the mechanism in practice — Suman Sahai calls Western bioethics a "bogus debate" not because the questions are wrong but because the frame excludes everyone whose bodies and crops are actually at stake. The pattern across these three texts is that ethics discourse in biotechnology consistently functions as a boundary-drawing exercise: it determines who gets to define "responsible" use, which is another way of determining who benefits. Eagleman's Bioethics Commission model of "deliberative democracy" attempts to solve this, but even bilateral dialogue presupposes that the relevant stakeholders can be identified and convened — an assumption that dissolves the moment you consider subsistence farmers whose genetic resources are being banked by institutions they've never heard of.